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INTRODUCTION
Trigeminal neuralgia is perhaps the most painful
disorder to affect mankind. The disorder is characterized by
its "seizure-like" attacks of pain to designated areas of the
face that are supplied by the trigeminal nerve. The
individuals who suffer from trigeminal neuralgia describe
its pain as unbearable, the equivalent of having a hot knife
cutting through their faces down to the bone.
One of the earliest descriptions of Trigeminal Neuralgia
was stated by Jurjani (1066-1136) . He described the pain to
affect the area of the teeth and jaw, and to occur in "spasm
like"
attacks. Jurjani didn't designate specific anatomy,
but concluded that the cause of the pain was due to the
constriction of a nerve by an artery. His hypothesis is the
earliest, most accurate theory proposed, thus supporting the
presently known etiology of the disease.
Unfortunately, many other individuals have misdiagnosed
the cause of trigeminal neuralgia. Crude attempts at
eliminating the pain have been as extreme as extracting full
rows of teeth, still leaving the patient to suffer the
painful spasms.
However, thanks to the many advances in research and
medicine, treatment of trigeminal neuralgia is now possible.
Specific medication and surgical procedures have given many
individuals freedom from its painful attacks.
INCIDENCE AND ETIOLOGY
Since there are many types of facial pain due to
abnormal dental, muscular, skeletal and neural abnormalities,
trigeminal neuralgia is usually hard to diagnose. Such
examples of facial pain that are common include: trigeminal
neuritis, characterized by a persistent state of
paresthesia; traumatic infraorbital neuralgia, similar to
trigeminal neuritis; and traumatic dental neuralgia,
paresthesias that occur after dental extraction. The
duration of trigeminal neuritis is constant, so it is treated
with continuous applications of analgesics; however,-
traumatic infraorbital neuralgia and traumatic dental
neuralgia have ends to their cycles. Eventually, paresthesia
ceases and normal sensation returns.
The incidence of individuals developing trigeminal
neuralgia in a given population occurs in an estimated ratio
of about 155 cases per 1,000,000 people. A further breakdown
of distribution among each sex is roughly 107 cases per
1,000,000 males and 200 per 1,000,000 females. The age of
acquiring the disease varies, but is usually found to affect
adults past the age of 40; however there are a few childhood
cases on record.
The pain attacks are usually experienced on the
right side of the face, though in some cases, bilateral tic
douloureux may exist. According to statistics, the most
frequently reported cases of the disease are said to be
diagnosed in women over 40 years of age and the pain
distribution is unilateral.
There seems to be a correlation among some people who
develop multiple sclerosis and also develop trigeminal
neuralgia. Multiple sclerosis is a neural disease that
cripples millions of people each year. During the clinical
course of multiple sclerosis, the myelin sheaths, which
enclose the nerve fibers, degenerate and thus, oligodendria
cease to function and ogligodendrocyte production stops. As
the myelin enclosing the epineurium degenerates, the nerve is
no longer insulated, making it more vulnerable to irritation
and injury. An important physiological trait of myelin is
that it has the ability to aid in the transduction of neural
impulses along axons, thus transmitting impluses quickly and
effectively to peripheral target structures. During the
course of multiple sclerosis, the outbreaks of demyelination
may be followed by periods of remission. As in the case of
trigeminal neuralgia, the cause of multiple sclerosis is
unknown. The demyelinOtion process occurs in the white
matter of the central nervous system. Areas often affected
include the optic chiasm, optic nerves, cerebellum, brain
stem and posterior cell columns in the spinal cord. As the
disease progresses, plaques form in regions of neural
demyelination. The plaques are the by-product of the
demyelination process and are macroscopic in size.
Although the causing factors of some cases of trigeminal
neuralgia are unknown, certain discovered physical
abnormalities can cause the condition. Vascular compression
and tumor growth are the most frequent etiological factors.
Vascular compression results from tension applied to a nerve,
usually its root, from the constricting proximity of a blood
vessel. Compression of the superior cerebellar artery to the
trigeminal root is a common occurrence in patients with
trigeminal neuralgia. The superior cerebellar artery, in
this situation, is trapped beneath the trigeminal root. The
blood flowing through the lumen of the vessel must build up
enough pressure to flow through the area of constriction. As
vascular pressure builds up inside the artery, the
endothelium stretches, causing the the vessel to expand.
This action triggers the pain receptors in the trigeminal
root to fire. This condition can be corrected by surgery.
The normal procedure would be to release the superior
cerebellar artery from its constriction between the
trigeminal root and the base of the pons.
Tumor growth can also be the cause of neurological
problems. Trigeminal studies have shown that tumor growth
along trigeminal pathways can cause pain, numbness and
paresthesia. Tumors can stretch, deform or compress the
nerve, thus sending afferent synapses of intense pain to the
thalamus, by way of the A-delta fibers. Tumors affecting
trigeminal pathways have been found in many regions
intracranially . These areas include the middle and posterior
cranial fossae, cavernous sinus, meckel ' s cave, foramen ovale
and areas around the tentorium cerebri. In many of these
sights of tumor compression, the tumor usually keeps growing
and will metastasize to surrounding tissues, unless surgery
or some other type of innervation is initiated.
MORPHOLOGY
The trigeminal nerve is the fifth and largest of the
twelve cranial nerves. It is a compound nerve, meaning that
it is capable of both sensory and motor innervation. The
trigeminal motor pathway contains one nucleus, while the
sensory pathway has three.
MOTOR PATHWAY: The motor nucleus of the trigeminal
nerve is located interpontine, slightly lateral to the
pontine medial plane and slightly inferior to the fourth
ventricle. It receives cerebral stimuli initiated from the
lower third of the precentral gyrus. These corticobulbar
fibers pass through the layers of the corona radiata,
internal capsule and cerebral puduncle and bury themselves in
a decussating fashion into the pons, prior to their junction
with the motor nucleus.
The motor root of the trigeminal nerve, portio minor,
emerges in an anteriolateral fashion from the motor nucleus
and projects itself through the tissue of the pons. As the
Motor Root leaves the pontine tissue, it is orientated
anteriomedially to the sensory root (portio major) , which is
the larger of the two. The portio minor continues
anteriorly, passing through the region of the posterior
cranial fossa and projects itself through the meningeal
tissue of the dura mater, inferior to the attachment of the
tentorium cerebri to the petrous portion of the temporal
bone. Still traveling rostrally, it enters a cavity in the
dura mater, which is orientated superiorly to meckel 's cave,
a depression in the petrous ridge of the temporal bone,
projecting under the semilunar (trigeminal) ganglion and
exits the intracranial space through the foramen ovale
(located medially in the middle cranial fossa) . After the
motor root exits the intracranial space, it joins with the
mandibular division of the trigeminal nerve, thus forming the
mandibular nerve. The mandibular nerve innervates the
muscles of mastication: the masseter, the temporalis and the
medial and lateral pterygoid muscles. Mandibular motor
fibers also supply the tensor tympani, a muscle found in the
osseous canal surrounding the eustacian tube; tensor veli
palatini, an outer layer of muscle located on the lateral
aspect of the posterior nares; and the mylohyoid and
digastric muscles, "strap muscles" of the ventral side of the
neck.
SENSORY PATHWAY: The sensory cell bodies of the
trigeminal nerve are located near the apex of the petrous
bone in the middle cranial fossa, within the semilunar
ganglion. Sensory fibers from the semilunar (gasserian)
ganglion travel in a dorso-medial fashion and enter the
tissue of the pons.
After the fibers penetrate the pons, the sensory fibers
distribute themselves to form three main nuclei within the
brainstem. The three major nuclei of the trigeminal sensory
pathway include the nucleus of the trigeminal spinal tract,
the main (principle) sensory nucleus and the mesencephalic
nucleus.
The spinal tract of the trigeminal nucleus is formed
after the trigeminal sensory fibers enter the pons. They
form a bundle-like mass extending to the caudal end of the
medulla and descend into the spinal cord. The trigeminal
spinal tract descends to the level of the third or fourth
cervical vertebra, where it fuses with lisseuer's tract. As
the spinal tract descends, it supplies fibers to the nucleus
of the spinal tract of the trigeminal nerve. The trigeminal
spinal nucleus has three subdivisions: the nucleus oralis,
the interpolaris and the caudalis. Sensory fibers from the
ophthalmic division descend to the second cervical level
where the fibers are the most ventrally oriented fibers of
the spinal tract. Fibers from the mandibular division
descend to the most rostral level of the trigeminal spinal
nucleus. The spinal tract pathway runs a course oriented
more dorsally than other spinal tract fibers. Fibers from
the maxillary division terminate in two different areas.
Maxillary sensory fibers, supplying the medial portion of the
face, nose and mouth, lead to the rostral aspect of the
spinal nucleus. Maxillary innervation to the lateral portion
of the face leads a spinal tract pathway that terminates in
the caudal end of the trigeminal spinal nucleus. Since the
maxillary division of the trigeminal nerve has two different
destinations in the afferent sensory pathway leading to the
central nervous system, it accounts for a unique pattern for
facial sensitivity. Spinal nucleus or spinal tract lesions
can cause a peripheral sensory loss to occur in the face.
The sensory loss occurs in
"onion-skin"
patterns and is found
predominently around the mouth or buccal area.
Afferent innervation from the face and mucous membranes
send impluses of soft touch, pain and temperature to the
spinal nucleus of the trigeminal nerve. From there,
neurosynapses travel craniad via the trigemino-thalamic tract
and are received in the ventral posteriomedial and
intralaminar nuclei of the thalamus.
The main sensory nucleus of the trigeminal nerve is
found posteriolateral to the trigeminal motor nucleus, inside
the pons. Afferent fibers supplying this nucleus transmit
messages conveying tactile stimulation and proprioceptive
impulses. The trigeminal main sensory nucleus sends
ascending impulses to the thalamus by way of the ventral
crossed trigemino-thalmic tract. The specific destination of
this nerve tract is in the thalamic ventral posteriomedial
nucleus.
The mesencephalic nucleus ascends from the main sensory
nucleus, cephalad, to the mesencephalic superior colliculus.
It receives synapses of proprioception from muscles supplied
by various motor nerves, as well as the trigeminal.
The regions of the face that are innervated by the
trigeminal nerve are grouped into three different divisions.
They are classified as the ophthalamic division (VI) ,
maxillary division (V2) and the mandibular division.
OPHTHALMIC DIVISION (VI)
The ophthalmic division of the trigeminal nerve can also
be classified as the ophthalmic nerve. The smallest of the
trigeminal divisions, its mode of innervation is strictly
sensory. The ophthalmic nerve supplies the nose, nasal
fossa, forehead, integument of the eyebrow and regions of the
orbital cavity inculding the lacrimal gland, ophthalmic
mucosa and the eyeball itself. The ophthalmic nerve
originates and branches off of the anterior superior aspect
of the semilunar ganglion. It projects in an occular
direction along the outer wall of the cavernous sinus.
Before entering the orbital cavity, it divides into three
branches within the sphenoid fissue. The subdivisions are
the lacrimal, frontal and nasal branches of the ophthalmic
nerve.
The lacrimal nerve, the smallest division of the three
subdivisions that make up the ophthalmic nerve, moves
forward, entering the orbital cavity through the sphenoidal
fissure. Its intraorbital path takes it along the superior
aspect of the lateral rectus muscle and continues forward
with the lacrimal artery to terminate into the lacrimal
gland, the conjunctiva and the superior palpebral fascia. It
also communicates with filaments of the facial nerve.
The frontal nerve is the largest of the three ophthalmic
subdivisions. It enters the orbital cavity through the
sphenoidal fissure and runs a superior and medially oriented
pathway above the levator palpebrae muscle. Still running a
frontal path, the frontal nerve bifurcates at the half-way
point inside the confines of the orbital cavity. It forms
the supratrochlear and supraorbital nerves. The smaller
supratrochlear nerve passes above the "pulley-like" structure
of the superior oblique muscle to enter the supraorbital
foramen. After its exit from the supraorbital foramen, it
takes an upward path along the forehead proximal to the
frontal bone and beneath the corrugator, supercilli and
frontalis muscles. Frontal nerve filaments also penetrate
through these muscles to supply the integument of the
forehead. The larger supraorbital nerve also projects
forward and through the supraorbital foramen to supply the
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upper eyelid and forehead. Supraorbital innervation
terminates in subcutaneous integument and pericranial tissue
of the frontal and parietal regions.
The nasal nerve enters the orbital cavity, running
between the two heads of the lateral rectus muscle, and
passes across the optic nerve, inferior to the superior
oblique and superior rectus muscles. It then enters the
anterior ethmoidal foramen, which is orientated on the medial
inner wall of the orbital cavity. After the nasal nerve
passes through the anterior ethmoidal foramen, it enters the
intracranial space, following a rostral path by passing
downward in a transverse fashion through a groove located in
the frontal aspect of the cribriform plate, part of the
ethmoid bone. The nasal nerve then runs through a slit
orientated proximal to the crista galli, also part of the
ethmoid bone. Still following a rostral direction, the nasal
branch of the ophthalmic nerve finally enters the nasal
cavity and there, the nerve bifurcates into two additional
branches, the internal branch and the external branch. The
internal nasal nerve innervates the olfactory mucosa of the
ventral aspect of the nasal septem. The external nasal nerve
follows a medially oriented path inside the nasal bone. It
descends to supply sensory innervation to the olfactory
mucosa of the frontal part and outer walls of the nasal
nares, including the inferior nasal spongy bone. The
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external nasal nerve then exits the nasal cavity between the
lower border of the nasal bone and lateral alar cartilage.
It descends beneath the compressor nasi muscle and supplies
the integumental tissue of the alar region of the nose and it
also communicates with branches of the facial nerve.
The ciliary ganglonic nerve branches off the nasal
nerve, oriented between the two heads of the lateral rectus
muscle. It continues frontally, passing along the lateral
side of the optic nerve and penetrating the neural tissue of
the ciliary ganglion, entering its posterior superior aspect.
It is sometimes joined by the superior division of the
oculomotor nerve.
The long ciliary nerves, usually two or three branches,
branch off the nasal nerve a short distance after the ciliary
ganglionic nerve branches off the nasal nerve. The long
ciliary nerves arise from their nasal nerve origin at the
point where the nasal nerve crosses the path of the optic
nerve. They join the short ciliary nerves which arise from
the ciliary ganglion and penetrate the sclerotic tissue of
the posterior aspect of the eye. The long ciliary nerves
continue their path in an anterior direction, running between
sclerotic and choroid tissues to finally reach their targets
of primary innervation. They supply the meridional and
circular fibers which make up the ciliary muscle group,
the iris and cornea.
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The infratrochlear branch arises from the nasal nerve
prior to the point of entry of the nasal nerve into the
anterior ethmoidal foramen. It runs anteriorly along the
superior border of the medial rectus muscle and joins a
filament from the supratrochlear nerve, located underneath
the "pulley-like" structure of the superior oblique muscle.
The infratrochlear nerve then runs to the inner angle of the
eye, supplying innervation to the integumentary tissues of
the eyelids, the conjunctiva, the lacrimal gland and the
lateral aspect of the nose.
THE CILIARY GANGLION: The ciliary ganglion is very
small, about the size of a pin-head. It is oriented in the
posterior portion of the orbital cavity. The ganglion is
embedded in fatty tissue and is situated between the optic
nerve and the lateral rectus muscle. The ophthalmic artery
usually lies medially to it.
The ciliary ganglion has three branches of
communication: the sensory root, motor root and the
sympathetic root. The ciliary sensory root arises from the
nasal nerve at a short distance from the semilunar ganglion,
and enters the ciliary ganglion inferiorly. The ciliary
motor root, sometimes divided into two parts, originates from
a branch of the oculomotor nerve, which supplies the inferior
oblique muscle. It joins the ciliary ganglion's
superior border. The third branch of communication of the
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ciliary ganglion is the sympathetic root, formed from a
single nerve branch originating in the cavernous plexus of
the sympathetic nervous system.
The ciliary branches of distribution, the short ciliary
nerves, are made up of six to ten fibers which branch off of
the ventral aspect of the ciliary ganglion. They form
into two bundle-like arrangements, with the lower bundle
being the larger. Their path runs ventrally with the ciliary
nerves and arteries, with one bundle above the optic nerve,
and the other bundle below it. They too, like the long
ciliary nerves, project through the ocular tissue of the
sclera and run forward to reach their target structures: the
iris, cornea and the ciliary muscles.
MAXILLARY DIVISION (V2)
The maxillary nerve is the intermediate of the three
trigeminal subdivisions, because of its position and size.
Its root originates from the ventral medial aspect of the
gasserian ganglion. The root projects forward, ventrally,
through the foramen rotundum, located along the inner ventral
wall of the middle cranial fossa. After its exit from the
foramen rotundum, the maxillary root passes the
sphenomaxillary fossa to enter the infraorbital canal,
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located inferiorly inside the orbital cavity. The maxillary
nerve path continues inside the sphenomaxillary fissure,
projecting in a slightly declined ventral angle to finally
reach the infraorbital foramen. The nerve then passes
through the foramen to the exterior. The major bulk of nerve
lies beneath the quadratus labii superioris muscle; however,
smaller branches of the infraorbital nerve travel to the
lateral aspect of the nose, inferior ocular region and the
upper buccal area. It communicates with branches of the
facial nerve in these areas.
The maxillary nerve has four branches of distribution:
intracranial, sphenomaxillary, infraorbital and facial
The maxillary intracranial distribution consists only of
the meningeal branch, steming off of the maxillary nerve, as
it originates from the semilunar (gasserian) ganglion. Its
path, which leads to the meningeal dura mater, joins the
pathway of the middle meningeal artery.
The sphenomaxillary distribution consists of three
subdivisions: the temporomalar , orbital; the sphenopalatine,
and the posterior superior dental branch.
The temporomalar branch originates within the
sphenomaxillary fossa. It enters the orbital cavity via the
sphenomaxillary fissure, where it bifurcates to form temporal
and malar branches. The sphenomaxillary temporal branch runs
a path along the lateral aspect of the orbital cavity,
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communicates with a filament from the lacrimal nerve and
passes through the malar bone via an osseous foramen to enter
the temporal fossa. It projects itself cranaid, running
along the lateral aspect of the frontal bone to the
temporalis muscle. It then pierces the tendonous tissue of
the temporalis and fascia to innervate the integumental
tissues of the lateral forehead and temporal area. In these
regions, the nerve will communicate with some filaments of
the facial and auriculotemporal branchs of the inferior
maxillary nerve. The sphenomaxillary-malar branch runs along
the external inferior angle of the orbital cavity; the nerve
then passes through to the face via a malar foramen and
penetrates through the orbicularis occuli muscle to supply
the skin of the cheek. In this external region, the malar
nerve filaments also communicate with filaments from the
facial and palpebral branches from the superior maxillary
nerve.
The sphenopalatine division is made up of two branches
which end their paths in the sphenopalatine ganglion.
The last subdivision of the sphenomaxillary branch
consists of the posterior superior dental branches. These
branches, which arise from the maxillary nerve prior to its
entry into the infraorbital canal, are usually made up of two
branches of nerves which give off fibers to supply the gums
and mucous membranes of the cheek. These fibers also enter
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the posterior dental canals of the maxillary bone and run
ventrally within the osseous tissue, thus joining with
filaments of the middle dental nerve. From here, fibers also
will branch through the dental alveolar region to supply the
molars and the pulp of the incisors.
The infraorbital distribution consists of two
subdivisions: the middle superior dental and the anterior
superior dental divisions.
The middle superior dental branch arises from the
maxillary nerve, within the ventral aspect of the
infraorbital canal. It descends ventrally, in the outer wall
of the antrum to supply the bicuspids. The middle superior
dental branch also communicates with the posterior dental
branch at the ganglion of valentin and with the anterior
dental branch at the junction called the ganglion of
bochdalek. However.- these are not proven to be actual
ganglia, the nomenclature given is strictly reference areas
for the separation points of the three dental branches.
The anterior superior dental division branches off of
the maxillary nerve prior to its emergence from the
infraorbital foramen. It descends through a canal in the
anterior wall of the antrum to divide into sub-branches which
supply the incisors and canine teeth. Being the most
ventrally oriented of the dental branches, its only dental
communication junction is with the middle dental nerve;
17
however, the anterior superior dental branch does give rise
to a nasal branch, which follows a rostral pathway to supply
the olfactory mucosa.
The facial maxillary distribution consists of three
divisions: the palpebral, the nasal and labial divisions.
The palpebral branches originate from the maxillary
nerve after its exit from the infraorbital foramen. These
branches ascend between the zygomatic bone and the
orbicularis oculi to supply sensory stimulation to the
conjunctiva and integumental tissue of the lower eyelid.
Malar and facial nerve fibers also communicate with the
palpebral branches.
The nasal branches follow a path to the lateral aspect
of the nose to supply its external integumental tissue.
Here, they will communicate with the nasal branch of the
ophthalmic (VI) .
The maxillary labial branches are the most plentiful of
the maxillary-facial distribution. These branches descend
beneath the quadratus labii superioris to supply integumental
tissue of the upper lip and oral mucosa. The labial branches
also communicate with filaments of the facial nerve to form
the infraorbital plexus which is located slightly inferior to
the orbit.
THE SPHENOPALATINE GANGLION: The sphenopalatine ganglion,
meckel 's ganglion, sits slightly inferior to the maxillary
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nerve root as it passes the sphenomaxillary fossa, proximal
to the sphenopalatine foramen.
Branches of communicaton include a sensory, motor, and a
sympathetic root.
The spenopalatine sensory root arises from the two
sphenopalatine branches which descend a short distance from
the maxillary nerve. Descending through the sphenomaxillary
fossa, some fibers terminate their pathway and enter the
sphenopalatine ganglion while other fibers end their paths in
the palat and nasal fossa. The sphenopalatine fibers that
enter the sphenopalatine ganglion make up the sphenopalatine
sensory root.
The sphenopalatine motor root of meckel 's ganglion
arises from the superficial petrosal branch of the facial
nerve.
The sympathetic root of meckel' s ganglion originates in
the carotid plexus, via the deep petrosal nerve.
Both the superficial petrosal nerve motor root and the
deep petrosal nerve sympathetic root join to form the vidian
nerve prior to its entry into meckel 's (sphenopalatine)
ganglion.
The superficial petrosal branch arises from the
geniculate ganglion of the facial nerve (VII) , in the
fallopii acqueduct. Its path runs ventrally, entering the
cranial cavity. It continues frontally through a groove on
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the anterior surface of the petrous region of the temporal
bone, inferior to the dura mater. The superficial petrosal
nerve then penetrates the cartilaginous tissue within the
foramen lacerum and joins with the deep petrosal nerve
branch to form the vidian nerve.
The deep petrosal branch arises from the carotid plexus
and runs through the carotid canal, lateral to the internal
carotid artery. It, being a tributary to the vidian nerve,
joins the superifcial petrosal branch after it enters the
foramen lacerum. As the two branches join, they give rise to
the vidian nerve.
The vidian nerve, after it is formed by the superficial
petrosal branch and the deep petrosal branch, follows the
path of the vidian canal. Arising from the otic ganglion,
the sphenoid branch ascends to join the vidian nerve, prior
to its entry into the sphenomaxillary fossa. The nerve then
terminates in the sphenopalatine, meckel 's ganglion.
There are four vidian branches of distribution: The
ascending branches lead to the orbit, the descending branches
lead to the palate, the internal branches lead to the nose,
and the posterior branches lead to the nasal fossa and
pharynx.
The vidian ascending branches comprising of two or three
slender filaments, enter the orbit via the sphenomaxillary
fissure, to supply the periosteum.
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The vidian descending branches distribute themselves to
the mucus membrane of the nose, tonsils, soft palate, and
roof of the mouth. They are distributed into three branches:
the anterior, the middle and the posterior.
The vidian internal branches supply the septum and the
outer wall of the nasal fossa.
The vidian superior nasal branches enter the posterior
region of the nasal fossa via the sphenopalatine foramen.
These branches supply the mucous membrane tissue of the
superior and middle spongy bones and the lining of the
posterior ethmoidal cells.
The nasopalatine nerve enters the posterior region of
the nasal fossa through the sphenopalatine foramen, as did
the superior nasal branches. As they enter the fossa, their
path runs medially across the roof of the nose, inferior to
the sphenoid sinus, until it reaches the nasal septum.
There, it then descends in an oblique fashion, anteriorly
along the lower part of the septum of the anterior palatine
foramen, between the periosteal tissue and the olfactory
mucosa. The nerves project downward through the anterior
palatine canal to the roof of the mouth. Two branches make
up the nasopalatine nerve, and are situated in the
intermaxillary suture. Within the mouth, the two branches
become united and supply the mucous membrane behind the
incisor teeth and also join the anterior palatine nerve. The
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nasopalatine nerve also supplies filaments to the mucous
membrane of the septum.
The vidian posterior branches are made up of the
pharyngeal and upper posterior nasal branches.
The pharyngeal nerve is a tiny branch that originates
from the posterior aspect of the pterygopalatine ganglion.
The pharyngeal nerve descends dorsally, with the
pterygopalatine artery, through the pterygopalatine canal to
supply the pharyngeal mucosa located behind the eustachian
tube.
The upper posterior nasal branches are few in number,
originating from the posterior aspect of meckel 's ganglion.
They run dorsally inside the vidian nerve sheath to supply
the mucous membrane of the nasal roof, the septum, the meatus
and also the eustachian tube.
THE MANDIBULAR NERVE (V3)
The mandibular nerve is the largest of the three major
divisions of the trigeminal nerve. It supplies the lower
jaw, including the teeth and gums, the external temporal and
ear region, the muscles of mastication and the tongue.
It has both a sensory and a motor root. The sensory
root descends from the inferior aspect of the gasserian
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ganglion. The motor root, the smaller of the two, also
descends beneath the gasserian ganglion to join the sensory
root after passing through the foramen ovale, as tbe roots
leave the intracranial cavity. After it exits the foramen
ovale, beneath the skull, the anterior and posterior trunks
seperate. Prior to this separation, a small meningeal branch
arises from the mandibular nerve to supply the internal
pterygoid muscle.
The recurrent branch arises from the mandibular nerve
after its exit from the foramen ovale. The nerve passes back
through the foramen spinosum to enter the intracranial
cavity, following the path of the middle meningeal artery;
the nerve bifurcates, forming an anterior and posterior
branch. The anterior recurrent branch communicates with the
meningeal branch of the mandibular nerve and supplies the
meningeal dura mater. The recurrent posterior branch
supplies the mucosa of the mastoid region and also supplies
the dura mater.
The masseteric branch runs forward, between the outside
boarder of the lateral pterygoid muscle (ventral to the
tempomandibular articular disc) and beneath the temporalis
tendon. It passes between the coronoid process and condyle
of the mandible, via the sigmoid notch. At this point, the
masseteric nerve shares the same route as the masseteric
artery. Both, supply the masseter muscle and branch through
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its tissue, some of the sub-branchings will travel as far
forward as the anterior border. Occasionally, a few
filaments may terminate at the mandibulotemporal articulation
or at the temporalis.
The mandibular deep temporal branches supply the
anterior and posterior borders of the temporalis along its
medial surface. There are typically only two branches of the
deep temporal division. The posterior temporal branch, the
smallest, is found at the posterior region of the temporal
fossa. Occasionally it will communicate with filaments from
the masseteric division. The deep temporal anterior branch
usually originates off of the buccal nerve. It ascends up
along the pterygoid aspect of the sphenoid bone, leading to
the frontal area of the temporal fossa. It terminates into
the anterior border of the temporalis. Atypically, there
exists a third deep temporal branch. It also supplies the
inner surface of the temporalis, with its innervation region
being the middle of the temporal fossa. The branch
originates off the buccal nerve and reflects over the
external surface of the lateral pterygoid muscle, up along
the sphenoid bone to terminate in the temporalis muscle.
The buccal nerve runs forward through the separation
between the superior and inferior heads of the lateral
pterygoid muscle. The nerve descends in one of two paths at
this point: either beneath the inner surface of the
24
mandibular coronoid process, or directly through the fibers
of the temporalis. It will reach the buccinator muscle and
bifurcate to form superior and inferior branches that ramify
forward throughout the muscle.
During the buccal nerve's earlier descent, between the
lateral pterygoid superior and inferior heads, tiny filaments
are given off. Some will supply the pterygoid muscles and a
few filaments will reach the temporalis. occasionally, a
filament or two will communicate with the deep temporal
anterior division and the superior branch of the buccal
nerve. The superior buccal nerve will communicate with VII
and also supply the integumental tissue of the upper
buccinator region. The inferior branch, reaching the lower
integument and oral mucosa, also joins with the facial nerve.
The external pterygoid nerve commonly arises from the
buccal nerve, however, it may originate directly from the
maxillary (V2) . It supplies the lateral pterygoid muscle,
entering it on its inner surface.
The posterior part of the mandibular nerve is sensory;
however, a few motor filaments supply it from its motor root.
Its three divisions include the auriculotemporal nerve, the
lingual nerve and the inferior dental nerve.
The auriculotemporal nerve branches off the mandibular
nerve at the level of the otic ganglion. Descending backward
beneath the lateral pterygoid muscle, the nerve then
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protrudes outward over the mandibular condyle. At this
point, the nerve climbs upward, under the parotid gland and
ascends over the zygoma to finally bifurcate into two
temporal branches.
The auriculotemporal nerve has two areas of
communication: one, being the facial nerve and the other the
otic ganglion. The facial nerve has two points of
auriculotemporal connection. The auriculotemporal nerve, as
it projects itself backward and out around the mandibular
condyle, joins with the facial nerve at the posterior aspect
of the masseter. Communication with the otic ganglion has
four points of neural junction: the anterior auricular, the
articular, the parotid and the superficial temporal branches.
The anterior auricular branch mainly supplies the
anterior part of the pinna (external ear) , and the integument
of the tragus and helix.
The articular branch supplies the area of articulation
between the temporal bone and the mandible.
The parotid branch supplies the parotid gland.
The superficial temporal branch supplies temporal
integumental tissue. As well as its facial communication,
the superficial temporal branch also joins a few filaments
with the temporomalar branch of the maxillary nerve (V2) .
The lingual nerve, also referred to as the gustatory
(tasting nerve) , supplies muscles and papillae of the
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anterior two thirds of the tongue. It branches off of the
mandibular nerve at the lingual-inferior alveolar
bifurcation. The lingual path runs anterior to the inferior
alveolar branch and descends beneath the lateral pterygoid
muscle, with the inferior dental nerve medial to it.
Occasionally filaments may communicate between the nerves.
The chorda tympani nerve joins the lingual nerve, posteriorly
at about a 45 degree angle. Still descending, the lingual
nerve passes down between the medial pterygoid muscle and the
inner surface of the mandibular ramus. Curving in at an
oblique angle, the nerve passes over the styloglossus and
superior constrictor muscles and also between the hyoglossus
muscle and the submaxillary gland. The lingual nerve runs
along wharton's duct (opening to the submaxillary gland) and
to the apex of the genioglossus muscle, superior long muscle
and inferior long muscle (all of which, make up the apex of
the tongue) below the oral mucosa.
The lingual nerve has four branches of communication:
the facial, the inferior dental, and the hypoglossal nerves
and the submaxillary ganglion.
The inferior dental branch is the largest division of
the mandibular (V3) nerve. Its path descends along with the
inferior dental artery, running beneath the medial pterygoid
muscle, then between the internal lateral ligament and medial
surface of the mandibular ramus. The nerve then enters the
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dental foramen and channels its path within the dental canal
of the inferior maxillary bone, inferior to the teeth, to the
mental foramen, where it divides into the mental and incisor
branches.
The four branches that make up the inferior dental
nerve include the mylohyoid, the dental, the incisive, and
the mental branches.
The mylogyoid nerve originates off the inferior alveolar
nerve prior to its descent through the dental foramen. The
mylohyoid nerve descends along the medial surface of the
mandibular ramus and runs under the mylohyoid to supply the
mylohyoid and digastric muscles.
The dental branches of the inferior dental nerve supply
the bicuspid and molar teeth. The nerve's fibers enter the
pulp of the teeth.
The mental branch exits the mental foramen and
subdivides beneath the depressor anguli oris. These
divisions innervate the integument of the chin and lower lip.
The dental branches also communicate with the facial nerve.
Two nerve ganglia are associated with the mandibular
nerve (V3) : the otic ganglion, with the maxillary trunk; the
submaxillary ganglion, with the lingual nerve.
THE OTIC GANLION: The otic ganglion is located
extracranially, inferior to the foramen ovale and medial to
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the inner surface of the mandibular nerve. It is situated
medial to the point of junction of the motor and sensory
networks of the mandibular nerve. The ganglion is lateral to
the eustachian tube and the origin of the tensor veli palati
muscle, anterior to the middle meningeal artery.
The otic ganglion has a vast network of communication.
It is exposed to sensory, motor and sympathetic modes of
neural innervation. It shares communication with the
external branch of the mandibular nerve by a few tiny
filaments. These filaments supply the otic ganglion with a
motor root and possibly a sensory root. Communication is
established with cranial nerves seven and nine. facial and
glossopharyngeal impulses reach the otic ganglion via the
superficial petrosal nerve, which arises in the tympanic
plexus. The glossopharyngeal probably supplies a sensory
root and the facial, a motor root. Sympathetic communication
is established from the middle meningeal plexus. Other
communication arises from the auriculotemporal and vidian
nerves.
The otic distribution includes only two areas: the
first runs backward along the lateral side of the eustachian
tube to supply the tensor tympani muscle; the second runs a
frontal path to supply the internal pterygoid muscle and a
single branch to supply the chorda tympani.
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SUBMAXILLARY GANGLION: The submaxillary ganglion
is relatively small in comparison to the semilunar
(gasserian) ganglion. It is "spindle-like" in shape and is
located in close proximity to the posterior border of the
mylohyoid muscle and superior to the submaxillary gland.
Its branches of communication include the lingual nerve,
facial nerve and the sympathetic plexus. Lingual nerve
communication is received by the submaxillary ganglion at its
anterior and posterior aspects. Communication from the
facial nerve travels via the chorda tympani. Sympathetic
innervation arises from the sympathetic plexus, around the
facial artery-
Branches of distribution originate from the inferior
region of the submaxillary ganglion. They include
approximately six branches. Target structures consist of the
oral mucosa (including wharton's duct, with additional
ramifications into the submaxillary gland) , the lingual nerve
and its connection with the frontal aspect of the sumaxillary
gland, the sublingual gland and the tongue.
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PATHOGENESIS:
There have been many different theories derived
throughout history regarding the pathogenesis of trigeminal
neuralgia. However, two main hypotheses prevail: one theory
states that tic doloureux is initiated from factors within
the central nervous system, and the other theory bases the
cause on peripheral factors.
Surgical innervention supports the "PNS (peripheral
nervous system) theorists. Peripheral etiological causations
include such occurrences as tissue inflammation, neoplastic
growths and lesions, and vascular (compression) of the nerve.
However, therapeutic nonsurgical medical treatment has
had an affect in suppressing pain in the trigeminal system.
The introduction of carbamazipine and baclophen have had
success in alleviating the abnormal pain associated with
trigeminal neuralgia. These drug treatments support the
theory of etiological factors within the CNS, specifically
the region of the trigeminal nuclei, nucleus oralis, within
the brain stem.
DATA SUPPORTING PERIPHERAL NERVOUS SYSTEM THEORY: The
most common physical etiological factors discovered in
patients suffering from the attacks of tic douloureux include
vasuclar compression from arteries of the pons, tumor
growths, and plaques deposited on the trigeminal root.
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Vascular compression is most commonly caused by the
abberrant location of the superior cerebellar artery, which
arises from the circle of Willis, constricting the trigeminal
root.
Neoplasms can metastasize with any tissue type, thus
promoting the trigeminal root to be subjected to ever
increasing neural compression unless the tumor is removed.
Plaques deposited on the trigeminal root are typically
found if a patient has had a history of multiple sclerosis.
Plaques are a by-product of the demyelination process.
Plaques are dark and tarrish in appearence. Those who had
suffered from the attacks of tic doulourex, during their
lifetime commonly were discovered to have plaque accumulation
when autopsies were performed. It is also clinically stated
that individuals who suffer from multiple sclerosis, have a
greater chance of developing trigeminal neuralgia.
Surgical sectioning of the trigeminal nerve has had
lasting success in some patients, giving them months or years
of pain free relief.
DATA SUPPORTING CNS (CENTRAL NERVOUS SYSTEM) THEORY:
Studies in animal laboratories, drug treatments and tests run
on patients with trigeminal neuralgia (both, before and after
surgery) have supplied valuable data reguarding the neural-
pathogenic actions of the trigeminothalamic system.
Clinical data involving tic douloureux attacks has lead
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to theorizing a CNS etiology. Such characteristcs include:
(a) a measurable period between the period of stimulation to
a "trigger area" and the violent attacks of pain, (b) soft
skin contact, which initiates the attacks, would normally be
interpreted as light, gentle tactile stimulation, (c) The
attacts are self-sustaining, following the initial "trigger-
area"
contact, (d) (the most astounding of all
characteristics) the intense pain associated with the disease
is experienced in regions of the face that are not in close
proximation to the trigger areas.
Experimentation performed on laboratory monkeys and cats
have lead to remarkable advancements in trigeminal nerve
research. Trigeminal root demyelination, manually induced in
the subjects, caused abnormal impulses to be experienced in
peripheral regions of the trigeminal nerve. This
neurophysiological phenomenon was alleviated after
intravenous introduction of the drug phenotoin was
administered, however, many of the subjects constantly rubbed
and scratched at their faces. This condition typically
ocurrs in people in treatment for trigeminal neuralgia. The
direct application of
"epileptogenic" agents to the spinal
trigeminal nucleus, in laboratory subjects, induced a tactile
state of hyperactivity in the faces of most of the animals.
The animals frantically displayed an avoidence reaction to
tactile stimulation. Some of the subjects reacted by
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scratching and pawing at their faces.
Partial sectioning of the preganlionic trigeminal root
resulted in abnormal afferent firing to peripheral branches
of the face; however, this condition passed after a period of
time, leaving the subject nonirritated. Total retrogasserian
rizotomys, however, resulted in more intense afferent firing,
with no point of duration.
Denervation of tooth pulps supplied by the maxillary and
mandibular divisions, supplying afferent impulses, resulted
in a noticable short-term increase in "low threshold action
potenials" in the spinal nucleus oralis. Tactile
hypersensitivity also occurred.
Different degrees of trigeminal nerve injuries cause
various types of perception. Typical mild injury or impact
to the trigeminal nerve causes a short-term pain firing.
High impact nerve damage results in constant A-delta (intense
pain fibers) firing to occur. Neural injuries involved in
trigeminal neuralgia are about in the middle, between soft
impact and intense impact.
After the destruction of trigeminal afferent fibers,
there is a definite increase in trigeminal efferent activity.
This abnormal activity results in a sensory condition known
as "dysesthesias", a burning itchy feeling which causes a
patient to constantly scratch or rub at their faces. The
hypothesis formed from this ocurrance is that a decrease in
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segmental (afferent) inhibition somehow causes the motor
pathways to overact. The afferent inhibition factor is the
primary hypothesis to the "trigeminal neuralgia, CNS
pathogenesis theory".
PATHOGENIC CONCLUSION: Data from both schools of
thought, the PNS theorists and the CNS theorists, have lead
to a pathogenic hypothesis involving a combination of both
theories.
Continuous irritation to trigeminal afferent fibers
causes abnormal afferent activity to be received by the CNS.
This produces a state of low-threshold "neural-mechanical"
activty to be lead to the trigeminal nuclei, thus producing
the painful tic douloureux attacks.
This information is derived from the most recent,
accurate scientific research performed. Basically, the most
viable hypothesis regarding the cause of trigeminal
neuralgia is that it has a peripheral cause, but, the
pathogenesis occurs within the central nervous system.
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CHARACTERISTIC PAIN PATTERNS:
Pathologic factors which could lead to trigeminal
neuralgia are very complex. The condition has many viable
explanations, each of which, is atypical of the normal
anatomical and physiological characteristics of the
trigeminal system.
During tic douloureux attacks, the trigeminal nerve's
synaptic mechanism is altered. There occurs a failure in
segmental inhibition of the afferent pathway. In other
words, the afferent fibers continue to fire even though the
initial nerve stimulation is no longer present.
The physical cause of the nerve vulnerability is usually
due to a change of the nerve's myelin sheath. In some cases,
it is due to demyelinaion (common in M.S.) while in other
cases, physical damage (such as a lesion or tumor growth) may
have occurred. Since one of main functions of myelin is to
serve as protection to the nerve, the neural fibers are much
more apt to be irritated, either physically or
physiologically, if the tissue is damaged or degenerating.
The tic attacks could be the result of a reflex
phenomenon because the impulse action is initiated by a
stimulus and the pain outlasts the stimulus. This is
followed by a short remission and then a period of
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refraction. The whole reflex cycle ceases when the afferent
impulses finally cease. This theory is based on ephatic or
cross-stimulation of proximal nerve fibers as a result of
demyelination or compression. The reflex phenomenon can
continue as long as the axonal tissue is capable of
conduction.
When a patient has a tic doulourex attack, there also
occurs a charge within the brain stem in the trigeminal
nuclei. In the spinal trigeminal nucleus, rostral aspect,
there is a marked state of internuncial hyperactivity. Since
there is a highly sensitized alteration in the
neurochemistry, afferent signals (even though the initial
stimulus was not a pain producer) are misinterpreted as pain
impulses. The amazing thing about the disease is that there
are times when trigger areas can be sitmulated without a pain
response.
If the specific nerves which convey the messages of
abnormal perception are not too severely damaged in
structural morphology, there may be hope within a period of
time for the patient. Postganglionic nerve fibers of the
peripheral nervous system possess remyelinating capability.
If the vulnerable nerves are again insulated, by regenerated
myelin, ephatic conduction is less likely to occur. Thus,
pain-free remission is a strong possibility if vulnerable
nerve fibers were the etiologic factor.
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Even though the previous information is based on very
viable theories and much of the stated data support actual
clinical cases which lead to successful alleviation of
patient suffering, there are no consistent trigeminal or
brain stem pathologic findings that distinctly lead to tic
douloureux. This statement is neccessary because there have
been many postmortem findings, such as demyelination, tumor
growths and lesions in patients who had not experienced any
history of trigeminal neuralgia.
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SPECIFIC LOCATION OF THE PAIN:
Clinical data gathered, regarding a large number of case
histories of trigeminal neuralgia, lead neurologists to the
conclusion that there is no set pain location specifically
found in every subject.
The disease is, however, commonly found to affect only
one side of the face. There are some patients who do suffer
bilateral pain, however this a relatively small percentage.
Bilateral tic douloureux is more common in family gene pools
and those who suffer from multiple sclerosis, than in the
general population. The time lapse for both sides of the
face to be affected, if the pain becomes bilateral, usually
takes a period of two or more years. It may, in some
instances, take a few days or up to 60+ years.
The initial onset of pain experiencd by a patient who
develops trigeminal neuralgia is usually found to irritate a
very small area. As the disease progresses, it may spread
upward, downward, vertical or in an oblique direction. It
may even affect more than one nerve track, but usually does
not involve an entire dermatome.
Henderson (1967) concluded some distinguishing data from
the treatment records of his patients. He designated two
regions of the face as common sensitive areas for tic
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douloureux attacks. The data gathered consisted of 650
clinical cases that he treated over a period of more than 17
years. He determined the most common area to be the "mouth-
ear zone" and the less frequent area to be the "nose-orbit
zone". The mouth-ear zone cycle usually originates in the
superior and inferior dental areas, specifically, proximal to
the canine and premolar teeth. Its progressive cycle of pain
travels either toward the ear or from one gum to the other.
The mouth-ear zone of pain was determined in 62% of his
patients. The second region of pain, designated by
Henderson, was found to occupy the nose-orbit zone and was
diagnosed in 33 percent of his patients. The nose-orbit pain
cycle emerges in the superior gum area much more often than
in the orbit. Its pain travels upward, toward the naso-
zygomatic area or to the temporal or nasal canthus.
Henderson found that tic douloureux pain very rarely
originated behind the orbital cavity or would spread from
that region toward the upper gum area. He never ranked this
in his percentage data because of its extremely low
incidence. Even though pain areas could move within a
region, with time, in 95 percent of Henderson's case studies,
the sensitized areas remained within the pain zone in which
they originated (even after follow-up examinations of over
20+ years) .
As far as general pain location is concerned, trigeminal
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neuralgia is more commonly found to affect the right side of
the face more than the left side by a 3:2 ratio. The
trigeminal nerve divisions most commonly affected are the
maxillary and mandibular (V2 and V3), either V2 or V3 alone
(being the second most common) and the ophthalamic division
(VI) being affected in the rarest of circumstances.
PAROXYSMAL PAIN: trigeminal neuralgia is classified as
a "paroxysmal" disease. A paroxysm is a seizure-like attack
of pain. The paroxysmal pain usually lasts between a few
seconds to a few minutes in time. The painful spasms
reoccurr after brief periods of freedom. The cycle of pain
and relief, pain and relief, can last over a period of
minutes, hours, days or even months. If the disease is left
untreated, the paroxysm attack periods last longer and
painfree intervals become shorter. There have been cases of
tic douloureux attacks lasting for years, until surgical
intervention was initiated. Periods of paroxysm remission
can last for a day, week or even up to twenty years or more.
Though the pain attacks commonly occur and diminish
usually over short periods of time, the pain emitted during
tic douloureux attacks is described as being the most
excrutiating pain known to man. Women who have suffered form
trigeminal neuralgia have declared that "tic
attacks"
produce
more pain than child bearing. There have been very few
instances of tic douloureux cases where the patient
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experienced pain at an extremely low level.
Upon cessation of a pain attack, it is not uncommon for
the attacked area to become "reddened" for a short period of
time. The patient frequently may experience a subtle warm or
burning sensation which will shortly pass. Nasal conjestion,
salivation, watery eyes or even a runny nose may also be
experienced post-paroxysm.
TRIGGER AREAS: Trigeminal neuralgia pain attacks are
commonly ellicited by light or gentle tactile stimulation to
an area of the skin which is supplied by a sensory nerve with
abnormal neurophysiology. Instead of transferring messages
of light touch sensation, the disorder causes jolts of
intense pain instead. The cutaneous sensitive areas on the
surface of the face, which when stimulated provoke this
reaction, are known as "trigger
areas."
Common normal stimuli which can cause tic douloureux
paroxysms are shaving, eating, talking, wind, nose blowing,
brushing teeth, washing the face and movements of the
tongue. . .ect. , even hair combing can be a stimulus in a few
instances (if the trigger area is supplyed by a temporal
branch of the ophthalamic nerve) .
The more frequent locations of trigger areas include the
lateral alar area of the nose, upper eyelid and the upper
and lower lip. Occasionally, trigger zones may develop
within the oral cavity. In some studies a few trigger areas
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in some studies, have been found to exist in gum and tongue
tissue. Most tic douloureux patients can usually detect
their trigger areas themselves, but in some cases testing
must be used to determine them.
The agony experienced by patients with the disease is so
intense, that for some, drastic measures are taken to avoid
trigger area stimulation. Trigeminal neuralgia victims have
been known to refuse to administer common hygiene practices
such as face washing, tooth brushing, shaving and even hair
combing. In very extreme cases, there have been patients who
went as far as refusing to eat. Suicide cases due to the
disease have even been recorded in chronic cases.
The amazing thing about trigeminal neuralgia is that
even though pain attacks can be initiated by a subtle
stimulation factor (and sometimes no stimuli at all) , tic
douloureux attacks generally do not occur during sleep. This
fact is very puzzling, because, it is very common to move
physically many times during sleep periods, especially the
head, neck and facial areas.
Though trigger areas generally inhabit the same
dermatome in which tic pain is experienced, trigger areas may
occupy different dermatomes than the areas that experience
pain.
The pain attacks of tic doulouruex leave patients
virtually helpless against instantaneous pain alleviation,
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until the paroxysms finally cease to initiate afferent
activity to the brain. This is usually the case, however, in
a very few instances. Patients may suppress pain by
administering various forms of tactile stimulation direcly to
the area experiencing pain. Modes of stimulation may include
furiously rubbing the area or direct applications of heat.
The etiology of this physiological phenomenon is based on the
principles of the gate control theory. The gate control
theory states: if there are two different types of tactile
sensation being experienced, one of the neural sensations may
block the transmission of the other. On a physiological
level, high frequency myelinated pain fibers are very small
and touch-pressure fibers are anatomically larger in
diameter. Therefore, the dominent transmission of tactile
messages inhibit the pain transmission in the central nervous
system. A common example of the gate control theory applied
is instinctively rubbing a painful bruise, or rubbing your
hands together when they are cold.
PHYSICAL CHARACTERISTICS: During tic douloureux
paroxysm attacks there is relatively little to be said
regarding visible physical characteristics.
If the diagnosis is of true (idiopathic) trigeminal
neuralgia, one of two sensory phenomenons may accompany the
tic. The first condition, a lowered sensitivity to ectopic
pain, is known as hypalgesia. The second condition is just
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the opposite. It involves an increased sensitivity to
ectopic irritation (hypergesia) . if one of these conditions
becomes present, it will diminish once the pain attack has
stoped.
If the disease is purely of symptomatic nature, physical
signs may include a lowering of corneal reflex reaction.
In a few cases, patients have experienced paroxysm
attacks with facial spasms. This condition is referred to as
"tic convulsif". The facial convulsions and the tic attacks
do not occur at the same time, but they do involve the same
side of the face.
DIAGNOSIS:
Symptomatic trigeminal neuralgia is diagnosed when the
characteristic pain paroxysms of tic douloureux exist and
either lesions or areas of trigeminal nerve demyelination are
the cause. The lesions may be a result of vascular
compression, tumor growth or trauma. Demyelinated areas may
be the result of progressing multiple sclerosis (M.S.).
Actual trigeminal neuralgia (etiologic) is diagnosed
when the typical pain characteristics of tic douloureux occur
and none of the causes of symptomatic tic douloureux
are present. If the diagnosis is actual trigeminal
neuralgia, the etiologic mechanism of the disease is a
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dysfunction of normal nerve physiology.
PAIN OFTEN MISTAKEN FOR TRIGEMINAL NEURALGIA: Chronic
facial pain disorders are often misdiagnosed, due to the
complexity of factors that can cause irritation in the head
and neck region. Actual diagnosis of trigeminal neuralgia is
made after being examined be a trained neurologist, who are
more familiar with specific pain neuropathies and
neuromorphology .
Types of pain experienced in the face may often times be
mistaken for tic douloureux. These disorders may include
temporomandibular joint dysfunction (TMJ) , atypical facial
pain, mygrainous facial neuralgia, cluster headaches,
postherapeutic neuralgia and glossopharyngeal neuralgia.
Temporomandibular joint dysfunction, whose etiological
cause is an imbalance of temporomandibular joint movement
produces a constant pain. Factors which contribute to this
condition may include trauma, degenerative arthritis,
bursitis and teeth grinding. T.M.J, can affect people of
all ages. Masticatory movements primarily initiate the pain,
the patients often experience recurring headaches; however, a
very notable factor differentiates this condition from
trigeminal neuralgia, because the pain associated with T.M.J.
is not induced be tactile stimulation.
Aytipical facial pain occurrs commonly in individuals
who suffer from chronic depression. Pain is usually
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experienced over an entire side of the face, sometimes the
whole head may become involved. Uncommon to tic douloureux,
atypical facial pain may be expericed outside trigeminal
innervation regions, trigger areas do not exist and emotion
is the sole cause of the syndrome. The patients who develop
atypical facial pain describe their experienced irritation as
an aching, dull, burning sensation. Sometimes they may also
experience a throbbing over the whole area experiencing
paresthesia.
The pain, characteristic of migrainous facial neuralgia
and cluster headaches, usually strike its victims during
specific times of the day and usually in a consistant
pattern. Unlike typical tic douloureux paroxyms, VII (facial
nerve) neuralgia and cluster headache attacks usually last
for periods of 15 to 30 minutes at the very least. They also
are not provoked by tactile stimulation, and pain may be
experienced on either side of the face at random.
Postherapeutic neuralgia primarily involves the
ophthalmic division of the trigeminal tract. The pain
expresses itself as a constant burning sensation. Sometimes
patients describe shock-like paroxyms whenever the eyebrow is
touched, on the side of the face where the paresthesia is
experienced.
Glossopharyngeal neuralgia is the closest in similarity
to trigeminal neuralgia. Glossopharyngeal (IX) neuralgia
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also possesses vital areas which can elicit pain attacks.
Common causes of glossopharyngeal neuralgia attacks include
coughing and swallowing. Since the pain of IX neuralgia is
like tic douloureux and is triggered be tactile movement, it
may at times be hard to diagnose. However.- there is a
difference between the two; glossopharyngeal neuralgia
usually ellicits pain in the tonsillar region and tonsillar
pain in trigeminal neuralgia is practically unheard of.
ASSOCIATION WITH MULTIPLE SCLEROSIS: There seems to be
a high incidence in those who develop multiple sclerosis to
also become afflicted with trigeminal neuralgia.
M.S. is a progressive demyelinating disease of the
central nervous system. The onset of the multiple sclerosis
usually occurs between the ages of 15
- 30. The first
periods of M.S. activity usually lasts a very short time,
between a few days to a few weeks. Symptoms experienced
during its clinical course include: clouded vision, loss of
sight in part of the visual field, paresthesia and pain
during eye movements, and a combination of numbness and
paresthesia on the face and all affected parts of the body-
After the original onset goes into remission, the patient
seems relatively normal again, however, future periods of
remission shorten and motor control and the effected parts of
the body slowly degenerate. As the demyelination process
continues, palsies develop throughout the periphery due to
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lack of neuralconduction.
The by-product of the demyelination process of multiple
sclerosis is black tarrish lessions called plaques. Plaques
are produced only after proximal ogligodendrocyte cells die.
It is by necrosis of these cells that myelin is no longer
produced.
The vulnerability of the sclerotic, non-myelinated nerve
axon leaves it more susceptible to irritation. Thus, the
possibility of developing symptomatic trigeminal neuralgia
is heightened. There is a 1 to 8 percent incidence of
patients who suffer from trigeminal neuralgia to also be
afflicted with multiple sclerosis and vice versa.
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CLINICAL TREATMENT
MEDICAL / MEDICINE-DRUG THERAPY: Due to the great
intensity of pain experienced during tic douloureux paroxyms,
preventative intervention must be taken. Pharmacological
measures are first applied, and, if they are ineffective,
surgical measures may be initiated.
CARBAMAZAPINE (TEGRETOL) : Carbamazapine is the number
one drug used in pharmacological treatment of tic douloureux.
It is often used during diagnostic testing in determining if
a patient has trigeminal neuralgia because, in most cases,
tic douloureux paroxysms will diminish upon initial
carbamazapine therapy. Carbamazapine commonly only
surpresses two pain disorders of the face, trigeminal
neuralgia and glossopharyngeal neuralgia. Since
glossopharyngeal neuralgia can usually be distinguished from
trigeminal neuralgia a specific pain diagnosis is more
evident.
At a metabolic level, tegretol abolishes the failure of
segmental inhibition in the trigeminal nerve, thus, causing
the cessation of nociceptive impulses in the nucleus oralis.
With segmental inhibition reestablished, normal circuiting of
afferent and efferent pathways are once again maintained.
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Upon initial administration of tegretol it usually takes
approximately 12 to 48 hours to become effective in pain
alleviation. If carbaemazapine intake is ceased, pain
paroxysm will again become active. After time, tolerance to
the drug may occur.- and after prolonged treatment,
carbamazapine may reach potentially toxic levels in the
bloodstream. Therefore, careful monitoring must be
maintained.
Carbamazapine is initially introduced to the body in
small amounts, beginning with doses ranging from 100 to 200
milligrams, twice a day. The medication is increased by
200mg every 48 hours, until an effective dose level (EDL) is
established or side effects are encountered. The average EDL
of carbamazapine varies between 600-800mg a day. If pain is
not suppressed once a patient's blood tegretol level reaches
maximum non-toxic levels, the drug is eliminated from
treatment and drug therapy is ruled out as a means of tic
douloureux supression.
Side effects which may be experienced from carbamazapine
include drowsiness, dizziness, gastrointestinal distress,
nausea, anorexia, giddiness and ataxia. Some of these
characteristics may only be temporary and cease as the body
adjusts to the presence of the drug. It must also be stated
that if tegretol therapy is discontinued, the patient must be
slowly weened from the drug. Abrupt tegretol elimination
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has been known, on rare occasions, to cause seizures.
BACLOFEN: Baclofen treatment has also had been
successful in its application to trigeminal neuralgia
therapy. baclofen, like carbamazapine, takes an active role
in reestablishing normal neurophysiology in the
trigeminothalamic tract. Both drugs alleviate the
nociceptive reflex action mechanism which provokes trigeminal
A-delta firing.
Initial administration ranges between 5 to lOmg every 48
hours, added until paroxysms diminish or side effects occur.
Stabilization of baclofen is usually achieved at an EDL
between 50-60mg per day.
The possibility of experiencing side-effects with
baclofen is much lower than with carbamazapine. Side effects
which may be experienced with baclofen treatment include;
drowsiness, dissiness and gastrointestinal disturbances.
Initial side affects experienced are usually temporary. If
baclofen is discontinued, after long-term use, it must be
eliminated at small doses at a time, or the patient may
experience seizures or hallucinations.
PHENYTOIN: Phenytoin has the lowest metabolic action in
trigeminal neuralgia pharmacotherapeutics. Its application
in tic douloureux treatment is to be taken in conjunction
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with baclofen. The synergistic action, created by the
ingestion of the two drugs, is required if the patient cannot
tolerate carbamazapine and pain suppression is not achieved
by baclofen alone.
Average phenytoin dose intake varies between 150-200mg
twice a day.
Side effects which may be experienced with phenytion
therapy include drowsiness, double vision (diplopia) ,
dizziness and ataxia. If any of these side effects persist,
they are usually only common in high doses. If phenytoin is
used in high dosage over a long time frame, irreversible
cerebellar damage may occur in rare occasions.
INITIATION OF MEDICATION: The objective of successful
drug therapy is to achieve optimal therapeutic results while
subjecting the patients to the least amount of risks and
complications. Therefore, drugs that present the least
amount of risks are the first to be employed upon treatment.
If the drug is ineffective in reaching the therapeutic goal,
other medications must be considered.
Typically, the first medication introduced during the
treatment of trigeminal neuralgia is baclofen. If pain
paroxysms do not cease, carbamazapine is the next
administrated. If baclofen or tegretol do not suppress the
paroxysms, an application of both drugs is the next attempt.
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If the patient has a tolerance to carbamazapine, a
combination of baclofen and phenytoin are then induced. If,
after all three drugs are administered throughout testing and
pain alleviation is not achieved, drug therapy is considered
ineffective in treating the specific case. Surgical
manipulation must now be considered.
SURGICAL INTERVENTION: If prolonged attempts at
treating trigeminal neuralgia with medicine are unsuccessful,
surgical intervention must be regarded as an alternative
means of temporary or permanent pain alleviation.
Even in patients who measure a therapeutic response to
drug therapy, surgery may present more beneficial results.
Surgery may be a better alternative, because of the
unpleasant side effects and possible irreversible damage
which may occur with long-term pharmacotherapeutic treatment.
Some of the surgical techniques are so minor that they
are performed routinely on an out-patient basis, and may
require only a local anesthetic.
However,- in other clinical
cases, a general anesthetic may be applied for up to 12 hours
prior to the procedure and may be continued in diminishing
doses of up to
48 hours post-operative time. The latter example is
considered a major in-patient operation.
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ALCOHOL BLOCK: The alcohol block technique, in the
treatment of trigeminal neuralgia, is the quickest, easiest
means of minor surgical intervention. Briefly speaking, this
method involves a percutaneous (through the skin) ethanol
injection directly into either the semilunar ganglion, or a
trigeminal peripheral branch. Since the injection is of pure
alcohol, the neural tissue will undergo partial necrosis.
However, over time, like other peripheral nerves, the
endoneurial fibers within the myelin sheaths, will be
resupplied with viable, conductive tissue. Thus, tic
douloueux attacks may once again return. Even though
paroxysms usually reoccur, the technique is so quick and at
such low risk to the patient, that it is an extremely popular
choice by both patient and surgeon. If the alcohol block
attempt is unsuccessful, the next procedure may be a
rhizotomy or a microvascular decompressive operation. This
Hypothesis is concluded from the alcohol block failure, since
the neurophysiological paroxym-elliciting region is not
distally peripheral, the cause must be proximal to the CNS.
MANIPULATION: Typically, the alcohol block is performed
at the origin of the nerve which supplies the tic douloureux
trigger areas. Therefore, all peripheral branches of the
injected nerve will be completely without sensation, until,
with time, regeneration occurs. For example, if trigger
areas are located in the submandibular ganglion region, the
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point of injection, typically, would be proximal to the
lingual junction of the inferior alveolar nerve. Thus, the
inferior alveolar, submandibular and submental regions would
be without sensation.
The local anesthetic should be applied directly to the
target area of the ethanol injection, because, it will
prolong the post-operative state of numbness. There must be
a reasonable time frame allowed between the anesthesia
application and the alcohol injection. The anesthetic can
mix with the ethanol, causing the alcohol to become diluted.
The average volume of ethanol used in the alcohol block
technique is approximately 0.5cc. Dosage may vary, but it
never exceeds 1.5cc per injection site. If more than one
injection target is required, the consecutive injection
should be initiated after at least 24 hours pass. All
injections should follow this rule, regarding alcohol block
therapy. For example, if 3 injections are required for
treatment, at least 72 hours should lapse between the first
injection and the third injection. This time period is
necessary because some patients experience
"tic-like"
pain
for at least 24 hours prior to pain alleviation.
During surgical manipulation, care must be taken during
the injection, because, if an artery (which supplies the
nerve) is injected, unwanted complications may occur. Since
the artery usually runs the same path of the nerve, and
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continually branches off more tributaries to the nerve, the
excess alcohol will keep flowing through distal parts of the
nerve, too. The potency of the ethanol may initiate an
endothelial break down and additional lesions may result.
Periods of pain freedom after alcohol block therapy
vary in clinical studies. Some freedom lasts only a very
short time, other cases have had remissions lasting over
thirty years. It seems that the outcome of the duration is
principally based on the regenerative properties of the
manipulated nerves. Therefore, the faster the growth rate,
the shorter the absence of pain.
Paresthesia may be experienced after treatment but
usually subsides with time (common in nerve manipulation) .
Other complications that may also pass include ocular muscle
palsies and general weakness of the face. In some cases,
herpes blisters may break out around the buccal-oral area.
The major change that patients have to adjust to is
desensitized facial regions. Since the manipulated nerve's
(or nerves') conductability has been erradicated, the priorly
innervated areas will be completely numb.
RADIOFREQUENCY GANGLIOLYSIS (THERMAL DESTRUCTION) : Like
the alcohol block treatment, radiof requency gangliolysis
therapy is a relatively low-risk proceedure. The objective
of the operation is to destroy nerve fibers within the
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semilunar ganglion or the trigeminal sensory root by using
direct applications of heat. An advantage that this
procedure has over the alcohol block technique is that
not all nerve fibers within the nerve sheath have to be
destroyed. In fact, in many cases of radiof requency
treatments, the patient may be pain free and may still
possess sensation in the effected trigeminal regions.
Another important factor favoring this therapy is that its
thermal application is limited to the proximal target
structure, where in the alcohol block technique, the risk of
ethanol spreading to ectopic viable tissue is relatively
high.
MANIPULATION: The patient is given a local anesthetic
while laying in a supine position. Once the anesthetic is
well in effect, a 19-guage, hollow needle is applied
percutaneously to the foramen ovale. Once the needle is
proximal to the foramen, the patient is given between 30-50mg
of methohexitol, for an additional anesthetic reaction. The
needle is then moved further, until it is situated superiorly
to the basilar groove of the sphenoid bone (clivis) . The
needle is then retracted a bit, in order not to puncture the
carotid artery and to also initiate the flow of cerebral
spinal fluid.
When entering the area of the foramen ovale, all three
trigeminal posterior root divisions are in close proximity.
58
During this procedure, a floroscope is used in order to
determine exact positioning of the needles applied.
Placement of the flouroscopic mechanisms are lateral, in
reference to the head.
Once the 19 gauge needle is in the exact location, it is
then withdrawn and replaced, by a radiof requency electrode.
The end of the electrode needle is capable of producing
be between 5-10Hz. The thermally manipulated area, may
include either all three trigeminal divisions, or just one.
The electrode needle is curved in order to give the surgeon
precise control upon gasserian penetration (since the nerve
roots run a curved path within the ganglion) and in order
to affect one division at a time.
Exact intraneural electrode placement is achieved (with
observable reactions of the face) during slight electrical
stimulation from the electrode. For example, if the radio
frequence needle tip is in contact with an ophthalmic (VI)
fiber, the ocular muscles may twitch, if the meedle contact
is with a sensory fiber of the mandibular division (V3),
either paresthesia or
"tic" pain may be expressed somewhere
within its innervation region. This surgical testing
determines not only morphographic intraneural location, but,
which areas must be manipulated during the procedure.
Throughout the operation, the needle is moved only 3-5mm at a
time. During this process, contacted fibers (eliciting pain
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to the face) are heated with radiof requency stimulation,
until the expressed "tic" is ceased. During gasserian
ganglion penetration, needle depth must not exceed 5mm
posterior to the clivis. When thermal stimulation is
initiated, the surgeon should take care to avoid motor fiber
contact. It is often inevitable to have some motor contact
because the objective of R.F. therapy is to achieve pain
refief without muscular palsies.
After the thermal applications are ceased, methohexital
is again injected and the patient is awakened. The surgeon
does tactile testing to the face in order to determine if
additional R.F. treatments are necessary. The patient is
carefully monitored for at least 15 minutes once hypesthesia
is achieved. If the patient is stable, hospital release is
usually the day following the procedure.
Successful percentages range from 78%-100% of treated
patients. Cases of reported failures usually result from
morphologic complications of the foramen ovale region.
Undesirable effects of radiof requency gangliolysis may
include muscle palsies, corneal hypesthesia, anesthesia
dolorsa and neuroparalytic keratitis.
PERIPHERAL NEURECTOMY: The peripheral neurectomy
approach to the surgical treatment of trigeminal neuralgia is
a relatively low-risk procedure. Eventhough the mode of
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anesthetic application is general, the dosage is so low that
this therapy is widely recommended, even to elderly pateints
and those who have chronic health problems. Another reason
for this proceedure's popularity is that unpleasent side
effects, such as ocular motor palsies, anesthesia dolorsa and
corneal anesthesia (which are possible side effects from
other neuralgia treatments) have not been reported in
peripheral neurectomy follow-up studies.
The basic approach to this procedure is to treat the
nerve eliciting the trigger, within the trigger zone and not
the area where pain paroxysms are experienced. The objective
of surgical manipulation is to completely cut the
nerve or nerves that innervate the trigger zone and whose
path leads to the region of paroxysm attacks.
The only notable draw-back of the peripheral neurectomy
proceedure is that since post ganglionic peripheral nerves
possess regeneration capabilities, the nerve fibers will
again grow and paroxysms will eventually return. Therefore,
this technique will need to be repeated as often as pain
reoccurs unless alternative treatment methods are considered.
MANIPULATION: Surgical manipulation is achieved by
incising the skin, reflecting tissue to expose the trigger
nerve, and making a complete sectioning. In cases where the
trigger area is proximal to a foramen, the nerve should be
sectioned as far back within the foramen as possible. This
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measure is taken to prolong the regeneration of the nerve to
its usual length. For example, if the affected nerve is the
supraorbital nerve, the site of sectioning will occur within
the supraorbital foramen. If the affected nerve is within
osseous tissue, a hole may be drilled in order to expose the
nerve for proper cutting.
This procedure relieves pain for approximately 2-3 years
(average) , however, some patients exceed 5 years of paroxysm
freedom. If the pain attacks are still experienced after the
neurectomy procedure, the administration of
"pharmacotherapy"
may suppress pain even if the medications were ineffective
before surgical measures were initiated. If paroxysms do not
cease following surgery and drug therapy, the neurologist
must consider the etiologic factor to be within the
trigeminal sensory root. If this is concluded, the following
surgical alternatives may include a rhizotomy, a tumor
removal or a vascular decompression procedure.
RHIZOTOMY (SECTIONING OF THE SENSORY ROOT): In cases
where the etiological instrument of a given case of
trigeminal neuralgia is not defined through the use of
medication, radiof requency gangliolysis, alcohol block
therapy, M.R.I, (magnetic resonance imaging) screening and
sometimes an M.D.V. (microvascular decompression) operation,
the next treatment approach (if neoplastic formations are not
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discovered) is directed at the trigeminal root.
Even though the rhizotomy approach is 80%-90% effective,
the procedure is not a common means of trigeminal neuralgia
treatment. The cases where the rhizotomy method is applied
results from a failure to find a vascular or other type of
neural compression during a MVD procedure. The incidence of
the preceeding condition ranges from approximately 14-21
percent in microvascular decompression procedures.
MANIPULATION: Two approaches to the trigeminal
rhizotomy technique exist. These surgeries include the
subtemporal procedure and the posterior fossa approach. Both
types of trigeminal neuralgia treatments require a general
anesthetic.
Subtemporal entry begins with an 8cm incision and a 2cm
deep cut ventral to the auditory canal (externally) . Once
the superficial tissue is reflected, an incision is also made
in the temporalis following the same direction as the muscle
fibers. When the temporal bone is exposed and a circular
hole is drilled, a 4cm craniotomy is performed. Dissection
is performed extradurally . The foramen spinosum is protected
by applying either cotton or wax directly into its opening,
and then the middle meningeal artery is divided. The
procedure continues to the foramen ovale. After some dural
tissue is dissected off the semilunar ganglion, the three
trigeminal branch origins are exposed. The order of branch
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encounter begins with the mandibular root (V3), the maxillary
(V2) root and finally the ophthalmic (V3) . It is very
important not to apply traction in the region around the
gasserian ganglion because injury to the facial or the
greater superficial petrosal nerve may result. Next, an
incision is made in the dural tissue (posterior to the
gasserian ganglion) to expand the area of neural
manipulation. As the incision is made, some cerebral spinal
fluid (of the dural cistern) will be released. The following
and most critical step of the rhizotomy procedure is the
actual root fiber sectioning. The sectioning is initiated
proximal to the lateral aspect of the semilunar (gasserian)
ganglion. As the fibers are sectioned, the ophthalmic fibers
are left unmanipulated, unless the tic douloureux paroxysms
are experienced within the ophthalmic division. It is
important that the motor root be not sectioned because
palsies and atrophy, especially of the temporalis and other
masticatory muscles, may occur. After proper sectioning is
complete, the dura is resectioned and the remaining incisions
are also closed.
Posterior fossa entry entails a retrogasserian approach
to sensory root sectioning (the same entry approach as M.V-
D.). When the root is exposed, it is cauterized then
sectioned. Like the subtemporal approach, the ophthalmic
nerve is usually spared and the V motor root is avoided.
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Since, in both procedures, the entire sensory root
system is not always destroyed, tactile sensation may be
saved in many areas of the face.
Clinical data reguarding the subtemporal approach shows
that the percentage of success is approximately 85%, deaths
from the procedure ranges from 0.8%-1.6%, facial atrophy
is 7%-8%; mild paresthesias at 56%; chronic (severe)
paresthesia 5% and neuroparalytic keratitis ranks at 15%.
Clinical data surveys of posterior fossa approach: 80%-
90% success, l%-2% death caused be surgery, 28% corneal
reflex weakness (50% minor facial herpes) , 8% severe
dysthesias, 20% mild paresthesias, 3%-8% minor facial
atrophy, 10% hearing imparement (in 50% percent of these
patients, the acoustic loss is permanent) . In rare
instances, the patient may be more prone to hematomas and
vascular complications.
Both procedures have very similar data results and the
objective of the two techniques is the same. Only a few
post-operative effects differentiate the subtemporal from the
posterior fossa surgeries. In subtemporal entry cases,
hearing impairment, or loss, has not been recorded. Patients
who have undergone the retrogasserian procedure have no
reported cases of postoperative keratitis.
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MICROVASCULAR DECOMPRESSION OF THE TRIGEMINAL ROOT: The
MVD operation has brought success in treating patients with
symtematic trigeminal neuralgia. The procedure may be
initiated if the patient is refractory to pharmacotherapeutic
measures and minor surgical techniques. Another factor
considered, in many cases, is the health and age of the
patient being considered as a candidate for surgery. Since
the microvascular decompression operation is a major surgery,
the mortality rate is higher to those of
high health risk and the elderly.
Pre-operative testing involves roentgenography, CT
scanning and angiograms. The major objective of these tests
is to study the morphological terrain of the posterior
cranial fossa. The goal is to define any vascular, neural or
osseous abnormalities which, if they exist, may be the
etiologic cause of the tic douloureux. There are instances,
however, that these anomalies may occur and be undiscovered
during testing. This occurs in a very low percentage.
MANIPULATION: The objective of MVD is to release a
blood vessel which is compressed between the trigeminal
sensory root (portio major) and the pons (the vessel
must be released to end the pain firing in the portio major) .
Twelve hours before operation time the patient is
administered lOmg of dexamethasone (an anesthetic) , in an
intramuscular injection. The anesthetic is continued
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throughout the procedure and 48 hours post-operative time
with dosages being tapered by 4mg every six hours. The
patient is situated in a lateral decubitis position. The
legs are secured with ace bandages, intubation is as well as
a central venous line and bladder catheter. The head is also
secured in a "pin head holder". To monitor the heart
properly, ultrasound is applied above the cardiac region.
The head is then bent until the chin is in close proximity to
the sternum. The head is turned slightly to the side. A 15-
20 minute I.V. line of 50g of mannitol is administered
shortly after intubation is stable.
Necessary head shaving is done and the head piece of the
operating table is moved into a horizontal position in order
to provide a rest for the surgeon's elbows.
A ventral retromastoid incision is produced,
approximately 7cm in length, 2cm medial to the mastoid
process of the temporal bone. The incision is cut in a
superior frontal path lateral to the hairline. The frontal
part penetrates through to the calvarial tissue and the
posterior part will penetrate deeper muscles. These muscles
are cauterized as they are incised. Muscles and fascia are
reflected from the calvarium, to prepare for a craniectomy.
The craniectomy, 3cm by 3cm, is then performed in the
area of the superior lateral region of the posterior cranial
fossa. The mastoid air cells are exposed from this removal
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and are coated with wax for protection. Now that the dura
mater is exposed efficiently, a U-shaped incision is cut.
The incision runs from the superior angle of the lateral
sinus down toward the periphery of the inferior aspect of the
calvarial craniectomy, back in an occipital direction, then
up again, still following the direction of the craniectomy -
The dura is then sutured in the two inferior lateral aspects
of the cut tissue. This flap is now pulled back, in a
craniad fashion to expose the brain and cerebellum. If there
is not enough room for surgical manipulation, more bone may
be removed.
The cerebellum is now retracted, from the lateral aspect
of its superior surface. A binocular microscope, using a 250
focal length objective, is now applied for the rest of the
procedure.
In cases involving trigeminal neuralgia of the
mandibular (V3) nerve, the target for vascular manipulation
is usually the superior cerebellar artery (see surgical
illustration) . Its course usually follows a craniad
direction around the pons, and bifurcates. One of the
branches, either the medial or lateral branch, is caught
beneath the trigeminal root's pontine entry. This abberrant
artery location causes the compression of the portio major,
which in turn, initiates the paroxysm reactions of tic
douloureux.
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With the cerebellum retracted, the area of the pontine-
trigeminal sensory root junction is cleaned by careful
dissection, until the morphologic structures are clearly
denoted. Next, the trigeminal root is stretched off the
pons by running a tiny piece of surgical tubing directly
around it. Just enough tension is drawn against the root to
allow for the trapped artery to be removed by micro-operative
surgical forceps. With the superior cerebellar artery still
withdrawn, the trigeminal root is then released from its
restrain, to its original position. A piece of tiny teflon
is next applied to the lateral side of the root. The
superior cerebellar artery is then placed on the lateral side
of the portio major with the teflon material laying between
the two structures. The teflon acts as a shock buffer and
absorbs some of the vascular pressure form the artery.
If the tic douloureux pain paroxysms occupy an area
which is innervated by the maxillary (V2) division, the
target vessel of manipulation is the superior petrosal vein.
The operative approach is basically the same as the superior
cerebellar technique.
Trigeminal neuralgia within the ophthalmic (VI)
division, requires vascular manipulation of the inferior
cerebellar artery. This procedure follows the same basic
guidelines of the other M.V.D. techniques. The success rate
of trigeminal microvascular decompression is approximately
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88%-89%. Successful outcome depends on the surgeon finding
the neural-vascular constriction and effectively releasing
it. If pain is still present following the operation, small
administrations of diphenylhydantoin usually suppress it. In
most cases, the irritation will cease in about 6-8 weeks.
This diminishing pain syndrome may occur in up to 40% of
clinical cases.
Post-operative surgical complications, which may arise,
include air embolism (usually not serious) 29%, facial herpes
21%, temporary hearing loss 15%, permanent hearing
loss 3%, serous otitis media 7%, aseptic meningitis 6%,
stitch abscess formation 6%, cerebellar hematoma 1%, subdural
hematoma of the posterior fossa 1%, hemispheric subdural
hematoma 1%, cerebellar infarction 2%, pneumonia 2%,
pseudomeningocele 2%, bacterial meningitis 2%, and death 1%.
Trigeminal neuralgia post-operative recurrences are
possible. This may result from improper manipulation, or in
some cases, failure of the surgeon to discover a tiny
compression. Tic douloureux recurrences require a second
operation. Target vessels manipulated in the second attempt
include: the superior cerebellar artery in 27.7%, anterior
inferior cerebellar artery 11.11%, anterior inferior
cerebellar vein 11.11%, superior cerebellar artery and vein
16.66%, superior cerebellar and anterior inferior cerebellar
arteries 5.55%, anterior inferior cerebellar vein and
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arachnoid cyst 5.55%, a prothesis caused irritation 5.55%,
slipped prosthesis 5.55% and a reactive prosthesis at 5.55J
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PROGNOSIS:
If a patient experiences extreme pain in spasm-like
attacks which fail to respond to analgesics and are not
caused by pain-evoking stimuli the pain paroxysms cease and
within minutes return again until the cycle finally
diminishes. A non-painful, proprioceptive sensation
(possibly a tingling feeling) is experienced somewhere on the
face prior to the pain attacks. These conditions may
indicate a probability of trigeminal neuralgia, as the
diagnosed syndrome.
If, after proper neurological diagnosis, the patient
truly has trigeminal neuralgia, the clinical longterm outcome
may at times vary. In most cases, however, the pain
paroxysms last longer when they occur and pain-free periods
shorten.
Since its prevalence in patients who suffer either nerve
trauma or a demyelinating disease is high, the patient's
neuromorphological viability status plays a major factor in
the outlook, if of the trigeminal neuralgia is caused by the
vulnerability or injury of the trigeminal nerve.
If nerve demyelination or plaque deposits are the cause
of the disease, areas of neural short-circuiting will spread
throughout the trigeminal periphery to future areas of
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demyelination.
If trauma is the causing agent, there may be some means
of surgical intervention applied to alleviate the condition.
The condition may also be produced by a nerve
compressing structure, such as a tumor growth or vascular
impinging. If tumor proximity is the cause, the tissue may
be removed. After vascular surgical procedures, vascular
compression may be relieved. If these symptomatictrigeminal
neuralgia initiating causes are not abolished, the tic
douloureux paroxysms will continue.
These prognostic data are based on the vast majority of
cases. However, there have been reported cases of
"symptomatic"
and
"idiopathic" trigeminal neuralgia patients
who have experienced short-term or long-term pain-free
periods.
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CONCLUSION:
The treatment of trigeminal neuralgia initially involves
drug therapy. If pharmacotherapy is ineffective, or
unbearable side-effects are encountered, surgical
manipulation is next step taken and is usually at least 80%-
90% effective.
Even though trigeminal neuralgia is not a fatal disease,
its pain producing paroxysms are unbearably intense. They
have driven some patients, in extreme cases, to commit
suicide. Since the exact pathogenic and etiologic mechanisms
are not entirely known, continuing research is required to
hopefully put this pain syndrome to clinical extinction.
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PROFILE OF THESIS WRITING:
Due to the fact that I am very new to writing a large
body of literature and scientific research-writing, the
thesis report was an extreme challenge for me. Thanks to the
guidence of Dr. Richard Doolittle, scientific advisor and
thesis consultant, I was able to develop a workable thesis
outline for the preceding body of writing. Advise from Glen
Hintz, medical illustration professor and "chief" thesis
consultant, and Professor Robert Wabnitz, medical
illustration advisor and thesis consultant reqarding medical
illustration literature, was essential feedback as well.
CONCEPTION OF THE TEXT: The objective of the
"Trigeminal Neuralgia, Through the Eyes of a Medical
Illusrator" text was designed to give an insight to the
neural disease, trigeminal neuralgia. The "audience" that
the scientific writing is designed for is medical students.
The writing, following the scientific text, explains the
thesis writing and illustration factors applied, as well as
my personal statement and conclusion.
LITERATURE RESEARCH APPLIED: My literature research
began during the summer of 1989. I was able to gain access
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to Falk Library of Health and Sciences, at the University of
Pittsburgh. While at Falk, I utilized books pretaining to
peripheral and cranial nerve research. The biggest influence
to my research and writing was a text written by University
of Pittsburgh professor, from the Department of Neurology,
Dr. Gerhard H. Fromm, M.D.. The text is entitled "The
Medical and Surgical Management of Trigeminal Neuralgia". I
read Dr. Fromm' s book, which gave me a good overview of the
condition of trigeminal neuralgia. But still, there was much
information that was very foreign to me, regarding
neurophysiology and neuronomenclature. I was determined to
contact Dr. Fromm to request an interview with him. After I
made a few contacts with University of Pittsburgh personel, I
was granted an interview by Dr. Fromm.
During the interview, I asked Dr. Fromm many questions
reqarding trigeminal neuralgia. He was very patient, and,
explained things to better help me understand some of his
literature, on a level that I could comprehend. He was very
kind and stimulating to talk to. I owe him a great deal of
thanks.
Among the other sources of text that I utilized while
doing my research were "The Physiology of Peripheral Nerve
Disease", Dr. Austin J. Sumner (University of Pittsburgh);
"Pheripheral Neuropathy, Volume II", Dr. Peter James Dyck,
Dr. P.K. Thomas, Dr. Edward H. Lambert, and Dr. Richard
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Bunge; "The Cranial Nerves", Dr. M. Samii and Dr. Peter
Janetta (University of Pittsburgh) . A great deal of the
"Neuromorphology"
section of the scientific writing was
researched from "Gray's Anatomy" by Dr. Henry Gray. Netter's
"Atlas of Human Anatomy" was also a great help.
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PROFILE OF THESIS ILLUSTRATIONS:
CONCEPTION OF IDEAS: Artistically speaking, portraiture
of the human head, throughout history, is regarded as a major
discipline among artists. Da Vinchi had the "Mono Lisa";
Rembrandt had his self-portrait series; Rubens had the
portrait studies of Elizabeth Brandt; and modern master
Andrew Wyeth made the subject of "The Helga Studies" a
memorable face among modern art collections. Though I am not
the caliber of these great masters, I too share their
interest in the artistic expression of human face and figure.
In this project, my objective was to use the human head
in a medical context, with neuroanatomy applied. I also
chose to incorporate a self portrait into the series as a
personal challenge.
OBJECTIVE OF THE RENDERINGS: My goal for the series of
illustrations was to indicate neural pathways and specific
anatomy in a visually pleasing manner and to use
four
approaches: portraiture, figure drawing, surgical
illustration and anatomy plates.
Plate 1: The self portrait illustration also indicates
the orientation of the brain, brain stem, semilunar ganglion,
cerebellum, and the trigeminal root.
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Plate 2: The neural pathways of the ophthalmic division
of the trigeminal nerve (VI) .
Plate 3: The neural pathways of the maxillary division
of the trigeminal nerve (V2) .
Plate 4: The mandibular division of the trigeminal
nerve (V3) .
Plate 5: The conceptual illustration, denoting the
orientation of the figure, cranium, spinal cord and posterior
cranial fossa anatomy, including reference to cranial nerves.
Plate 6: The pen and ink surgical illustration
illustrates the microvascular decompression technique, common
in trigeminal root manipulation, involving vascular
impingament. This procedure is perhaps the most popular
major surgery involving tic douloureux.
MEDIA USED: Artistic media incorporated into this
project are what I would classify as quick media, among other
forms of medical illustration applications.
Media which would require much more time in the actual
rendering applications may include the air brush, watercolor,
acrylic painting and the carbon dust technique.
The applications used in this project include pastel,
colored pencil, cartoon color paint and the pen and ink
technique.
My goal was to develop quick and competent rendering
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techniques for successful full-color illustration. I believe
that this was a good objective for me to undertake because my
portfolio showed a weakness in my color work. It was missing
the punch that it needed to stand alone as color
illustration.
I also chose pen and ink for one of the illustrations.
My drawing technique tends to lend itself to a linear style,
so it would be a more natural media to adopt. Since the pen
and ink illustration denotes a complex surgical procedure, I
used a clear and simple way to show it. Pen and Ink is a
fast media and when done effectively, form can be understood
very easily.
The pastel-colored pencil illustrations (Plates 1-5)
were rendered using Prismacolor colored pencils, Berol pastel
pencils, Nupastel color sticks, HB mechanical pencils,
cartoon color paint and touches of titanium white acryllic
paint.
TECHNIQUES APPLIED: The self-portrait (brain,
cerebellum, brain stem, trigeminal root orientation)
illustration shown on plate #1, was rendered in a series of
steps.
The first step was to draw a self portrait for
reference. This was done from direct observation by using
two mirrors, at angles, in order to capture a profile view.
80
Drawing from direct observation, "life", is a common
discipline that I feel not only inhances draftmanship
ability, but also enables the artist to observe three-
dimensional form. If using a photograph, the artist would
see form on a two-dimensional image. This is an essential
practice of an illustrator, since models are not always
available; however, the traditional practice of "life
drawing" is a rudimentary and necessary discipline.
The original self portrait study was rendered using a
4B pencil. It was drawn on news print, sprayed with a
fixative and transferred by using tracing paper and pencil
tracings onto a piece of peach-flesh Canson paper. Once the
graphic image was on the paper, a flesh colored pastel pencil
was used to apply an even tone of dark flesh color to the
face. The tone was then smoothed, using a sable brush, until
a flat medium-flesh color was achieved over the whole area of
the face. Next, lighted areas where manipulated into the
drawing, using an eraser to erase the dark flesh and to leave
the light color flesh of the Canson paper to show through.
Shadows of the nose, eye, chin, lip and cheek area. . . .ect. ,
were achieved by applying very subtle tone with a #2 graphite
pencil. The graphite was mixed with the pastel color. Care
must be taken when using the graphite application because if
too much graphite is applied, the paper texture will become
waxy and pastel applications will not adhere to it.
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As the drawing took shape, the Prismacolor colored
pencils were used to reinforce the form of the facial anatomy
and to make the illustration stand out better. The colored
pencils were also used in the finishing touches of the
illustration. A bold contour line was drawn around the
portrait and certain anatomical regions were also emphasised.
This technique was a new approach for me, but I found it
created a more dynamic image.
Many achievements of an artist are developed by trial
and error when drawing throughout his or her life.
Accidental discoveries are also a major contributer to an
artist's technique. I owe much of the success of the thesis
illustration series on trial and error and "happy accidents".
The next step of the self portrait was to add the hair.
This was done by first applying a brown pastel which was
smoothed to create an even brown tone, then brown colored
pencils were used to create variations in dark and light.
Titanium white was then applied to add a refective
quality to the eye. After this process, a
"fixative"
was
sprayed onto the illustration.
The final objective of the self portrait was to create
an acetate overlay to designate specific anatomy. Wet media
acetate was used because the rendering would be done using
the pen and ink technique. Once the brain, cerebellum, brain
stem and trigeminal root were denoted in the drawing, parts
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of the illustration were introduced to the stipple technique,
in order to show shadow. "Stipple" is creating dots, which,
when successful, will read as tone. More conglomerated areas
of the dots will create darker areas, for shadows and darker
regions of a illustration.
Plates #2-4: The ophthalmic, maxillary and mandibular
divisions of the trigeminal nerve are illustrated in this
series.
This series of drawings was a tremendous big break
through for my knowledge of color application. The
previously discussed artistic growth through the trial and
error philosophy went into full play. I recall roughly eight
to ten unsuccessful illustrations during my attempts to
devise a successful color formula for bone color and the
background color. A major problem was encountered when I
tried mixing extravagant colors for bone. This technique
does work for some artists, but for me, it was an out of
control mess. Being very frustrated, I sought the advise of
my fellow classmates and instructors. Sometimes when working
continuously on a project, it is good to get feed back from
other sources because they may see mor clearly any flaws or
defects in an illustration. My intuition was correct,
because, after evaluation of my flops by my colleages:
Joeseph Bloch, Dean Vigyikan and further evaluation from
professors Glen Hintz and Robert Wabnitz, I was stimulated
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with fresh solutions to the problem solving process for the
trigeminal nerve anatomy illustrations.
Advice such as "Keep it simple" from Professor Wabnitz
and from Professor Hintz; "Apply the basics of analogous
color
theory"
was essential to solving my problem. It is
very easy to become overwelmed with something that you labor
over, sometimes in frustration, and to overlook the simple
basics of success. This statment may be applied to many
things in life. The conversations that I had with my
colleagues, as well as friends, Bloch and Vigyikan, were
equally valued. They were more on the humorous side, which
was exactly what I needed - a light hearted way to view the
challenge and boosted my morale.
After careful personal evaluation and the gathering
of ideas from my peers and instructors, a successful color
theory was developed. To keep the color composition of the
series consistant, the same color background which was used
for the self portrait illustration was incorporated into the
nerve branch illustrations. The bone color formula was
rendered in yellow ochre, for the base color and burnt umber
for the shadows and contour lines. Yellow ochre was first
applied by using a Berol pastel pencil. Burnt umber
prismacolor pencil was added to the yellow ochre decreasing
its value. This mixed media application was very successful
and possible complications such as the waxy texture, which
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can be encountered using graphite and pastel did not arise.
Using the same color background color was a wise choice
because it kept the orientation drawing (plate #1) and the
nerve anatomy illustrations (plates #2-4) consistant. Yellow
cartoon color, an opaque bright paint, was very effective in
making the nerve branches stand out. For the trigeminal
nerve branches that run underneath bone, the burnt umber
contour lines were applied in a dotted pattern.
Plate #5, the conceptual illustration, illustrates
the orientation of the figure - cranium, spinal cord,
cerebellum, view of the posterior cranial fossa and reference
to the cranial nerves.
The first step was to render the figure. This, like the
self portrait, was drawn from "life" or direct observation.
Prismacolor colored pencils were used in blue-violet for the
darks and white for the lights. My objective was to keep the
figure drawing more consistant with its blue background and
render the two other illustration insets in color in order to
make them stand out.
The posterior cranial view and the craniectomy, showing
the posterior region of the brain, cerebellum, cranial
nerves. . .ect. , were rendered in ochre, burnt umber, yellow,
beige, pink and white. Pastel pencils were used for the
ochre, beige and pink colors, pastel pencils and white
charcoal were used for the white color, and cartoon color
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paint was used for the yellow color.
I chose a blue background because I wanted this
illustration to stand apart from the first four plates in the
series. It was a different approach.
The final illustration (plate #6), the surgical
procedure, was rendered using, perhaps, my favorite
technique, pen and ink. Pen and ink is a very straight
forward approach to medical illustration. When applied
properly it is very traditional and effective in producing
easy to read imagery. It is probably my most natural media,
due to the fact that much of the tonal areas that I render,
while sketching and drawing, are achieved using linear
variations.
This illustration designates the microvascular
decompression procedure, as it applies to trigeminal root
manipulation. The orientation drawing (upper left of plate
#6) shows the initial incision and craniectomy targets for
this "retromastoid approach". Rendering "A" denotes the dura
matter exposed after the craniectomy is performed. Rendering
"B" illustrates the dura matter incised in a U-shaped manner
and reflected upward to expose the brain tissue , while the
cerebellum is in the action of being reflected backward, in
order to make the trigeminal root at the base of the pons
visible. Renderings
"C-E"
show a disecting microscopic view.
Rendering
"C" illustrates the vascular impingament of
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the superior cerebellar artery. The dotted line pattern is
effective in making the artery read as being under the
trigeminal root.
"D" illustrates the manipulation process of lifting the
trigeminal root with a retractor and the actual removal of
the artery from beneath the root by using forceps.
Rendering "E" indicates the final objective of the
procedure. The superior cerebellar artery is placed on top
of teflon material which serves as a vascular shock absorber
between the nerve root and artery. The tonal looking area,
teflon material, of the illustration was achieved using
zippatone film, a f risket-like, tansparent-adhesive plastic
which can be cut to any two dimensional shape and applied to
an image. It is used to represent a dark or shadowed area.
The film has dot patterns on it and the conglomeration of the
dots create an overall area of tone.
All lettering used on the illustrations were applyed
using rub-off lettering.
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ILLUSTRATION RESEARCH: Research done for this project
included many illustration references: The "AMI Sourcebook
various "Journal of Biomedical Communication" mannuals,
advertising "Black Books", pharmaceutical advertisments and
studies done by "mentor" illustrators, including Karen
Vissor, a personal friend and an inspiration.
88
ARTIST'S STATEMENT
Becoming a medical illustrator has been my goal for the
past eight years. Before I set my mind on making medical
illustration a major part of my life, I was very frustrated.
Even though drawing had been a hobby since my childhood,
something was missing in my spirit, especially during my
sophmore year as a Fine Art's major at Edinboro University of
Pennsylvania, in 1984.
I became discouraged, because I knew that I was missing
something in my life. Though I was talented in the fine art
area, my art work no longer served its purpose in satisfying
me. Dismayed with laboring over still-life drawings and
design problems, and no intellectual stimulation, I finally
decided to get out of art all together and use my art as a
hobby.
I approached my advisor, Professor James Vredovogue,
(Edinboro University, fine art professor) and proclaimed, "I
want to change my major". He was concerned because I had
made much progress under his instruction. He was not only my
trusted teacher, but was also a friend. He advised me not to
change my major just then, but, to take a
semester off from
art courses and take other types of classes, just to see if I
could gain an interest in any other field of study.
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During the following semester, I took two general
biology courses called "Man and Nature" and "Health and Human
Sexuality". That 15 weeks stimulated my interest in learning
more about the human body and how it worked.
It was also during that particular semester that I
became friends with Scott Williams. We were fellow atheletes
on the "Edinboro University, Fighting
Scotts"
swim team.
Scott was an outstanding athelete and I heard that his
reputation as an Edinboro fine art student was phenomenal. I
discussed Scott's future artistic plans with him and found
that he planned on pursuing a career in medical illustration.
This was a new field to me.
A very short period of time passed during the semester
and I came to realize that I did have artistic blood in me
and even if I tried escaping, I could not let go of my love
for drawing. Since I did not have any art courses that
semester, I would stay up half the night drawing for my own
enjoyment.
My interest continued to grow in biology and the study
of the human body. I routinely visited Scott in his studio,
asking him more about medical illustration. The following
semester Scott and two of his fellow classmates had an art
show. When I saw Scott's anatomical and figure studies,
I knew then that this was what I wanted to do. I sought
Scott's advise many times. He was very helpful and
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inspirational.
Another person who was very influential in my interest
in human anatomy was Edinboro University art professor, James
McMurry. Professor McMurry is, by far, one of the most
incredible artists that I have ever encountered. His
instruction was very precise, articulate, strict and
intellectually challenging. He would challenge your artistic
skills to the limits of creativity and accuracy. His figure
drawing instruction was excellent. He, like Scott, gave me
the much needed academic guidance and advise.
During my medical illustration training at the Rochester
Institue of Technology, Professor Robert Wabnitz and
Professor Glen Hintz greatly influenced me. Robert Wabnitz
is well known among medical illustrators across the country,
having done illustrations in Gray's Anatomy and various
orthopaedic sugery atlases just to name a few. Professor
Wabnitz was very patient with me upon my initial attempts in
medical illustrating. I was new to the techniques that he
had mastered and he was able to see my perspective as a
beginner and worked with me often individually. His most
accomplished medical media is the carbon dust technique. The
most valuable technique that I learned from Professor Wabnitz
is the ability to improvise shadow and light, to make
illustrations tonally dynamic and more volumetric. Professor
Hintz introduced me to very versatile ways to render medical
91
illustrations. His accomplishments with air brush, pen and
ink, water color, and schematics are very motivating for
students to see. Professor Hintz has the ability of making
you see things in illustrations that you normally would not
see. During my studies under Glen, he was able to see the
strengths and weaknesses of my artistic ability. He helped
me capitalize on my strong points and improve my flaws. The
best thing that Professor Hintz taught me was that I did not
have to completely change my drawing technique to do medical
art. Unlike many medical illustration colleagues of mine, I
tend to favor rendering dark or shadowed areas with line
variations instead of solid tone. I thought that I would
have to change my whole drawing approach to achieve more
success, but Glen encouraged me to use my line style to
develop a stronger pen and ink ability.
Professor Wabnitz and Professor Hintz were very helpful
in stimulating class-room morale. Their humor also helped to
break the ice during a rough day. I was very grateful to
become their medical illustration graduate assistant during
the 1990-1991 school year.
This "Artist's
Statement" is devoted to all those who
helped me grow artistically, many are unnamed, but certainly
not forgotten.
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CONCLUSION
The "Trigeminal Neuralgia, Through the Eyes of a Medical
Illustrator"
project has been a very draining experience for
me to undertake. I am pleased that I chose a neurological
topic to research, because the subject of neurophysiology
always intimidated me. Completion of this research gives me
a sense of pride.
It is my goal to continue my growth as a medical artist.
Learning more about art enhances my creative lust, learning
medical information stimulates my ego, being a medical
illustrator gives me integrity.
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